Cero Therapeutics Announces $14.6 Million Private Stock Sale to Institutional Investor
I'm PortAI, I can summarize articles.
Cero Therapeutics Holdings Inc. has announced a private stock sale agreement with an institutional investor to issue and sell up to $14.6 million of its common stock. This agreement continues the company's previous equity line arrangements. The sales will be made in a private placement without registration under the Securities Act, with each transaction capped at 10,000 shares or $100,000.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments